PATENT CLAIM ANALYSIS

Application Number: 15742249
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
Compositions including a recombinant respiratory syncitial virus (RSV) Fusion (F) polypeptide that is stabilized in the pre-fusion conformation are described. The RSV F polypeptide includes at least one mutation as compared to a wild type RSV F polypeptide and the at least one mutation is a) a mutation of the amino acid aspartic acid (D) on position 486, b) a mutation of the amino acid aspartic acid (D) on position 489, or c) a mutation of the amino acid serine (S) on position 398 and/or the amino acid lysine (K) on position 394. Compositions including an isolated nucleic acid molecule encoding the stable RSV F polypeptides are also described.

Claim (Index 5):
The composition according to  claim 1 , wherein the mutation of the amino acid at position 489 is a mutation from aspartic acid (D) to tyrosine (Y).

Metadata:
- Claim Count in Document: 10.0
- Percentile: 86.0
- Lexical Diversity: 2.04762
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15385611', '15742265', '14899531', '15545218', '14776651']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7603784240202879
- 35 USC 102 Novelty (BERT): 0.5332292422668734
- Combined Prediction Score: 0.7376635058449464
- Mean Citation Score: 318.546202
- Max Citation Score: 360.10843
- Similarity Product: 260.6282169257486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test